ir.alpineimmunesciences.comAlpine Immune - Investor Relations
ir.alpineimmunesciences.com Profile
Ir.alpineimmunesciences.com is a subdomain of alpineimmunesciences.com, which was created on 2014-10-28,making it 9 years ago.
Discover ir.alpineimmunesciences.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.alpineimmunesciences.com Information
| HomePage size: 85.507 KB |
| Page Load Time: 0.120553 Seconds |
| Website IP Address: 162.159.129.11 |
ir.alpineimmunesciences.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
ir.alpineimmunesciences.com PopUrls
| Alpine Immune - Investor Relations https://ir.alpineimmunesciences.com/overview/default.aspx |
| Vertex Enters Into Agreement to Acquire Alpine Immune Sciences https://ir.alpineimmunesciences.com/news/news-details/2024/Vertex-Enters-Into-Agreement-to-Acquire-Alpine-Immune-Sciences/default.aspx |
| Alpine Immune Sciences Provides Corporate Update and Reports Fourth ... https://ir.alpineimmunesciences.com/news/news-details/2023/Alpine-Immune-Sciences-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2 |
| Alpine Immune Sciences Announces Proposed Public Offering https://ir.alpineimmunesciences.com/news/news-details/2023/Alpine-Immune-Sciences-Announces-Proposed-Public-Offering/default.aspx |
| Alpine Immune Sciences Announces Initiation of Dosing in 240 mg IgA ... https://ir.alpineimmunesciences.com/news/news-details/2023/Alpine-Immune-Sciences-Announces-Initiation-of-Dosing-in-240-mg-IgA-Nephropathy-Cohort-of-P |
| Alpine Immune - Alpine Immune Sciences Provides Corporate Update and ... https://ir.alpineimmunesciences.com/news/news-details/2024/Alpine-Immune-Sciences-Provides-Corporate-Update-and-Full-Year-2023-Financial-Results/defau |
| Alpine Immune Sciences Reports First Quarter 2024 Financial Results https://ir.alpineimmunesciences.com/news/news-details/2024/Alpine-Immune-Sciences-Reports-First-Quarter-2024-Financial-Results/default.aspx |
| Alpine Immune Sciences Reports Third Quarter 2023 Financial Results https://ir.alpineimmunesciences.com/news/news-details/2023/Alpine-Immune-Sciences-Reports-Third-Quarter-2023-Financial-Results/default.aspx |
| Alpine Immune - Alpine Immune Sciences Provides Corporate Update and ... https://ir.alpineimmunesciences.com/news/news-details/2022/Alpine-Immune-Sciences-Provides-Corporate-Update-and-Reports-Second-Quarter-2022-Financial- |
| Alpine Immune Sciences Reports First Quarter 2023 Financial Results https://ir.alpineimmunesciences.com/news/news-details/2023/Alpine-Immune-Sciences-Reports-First-Quarter-2023-Financial-Results/default.aspx |
| Alpine Immune - Alpine Immune Sciences to Report Fourth Quarter and ... https://ir.alpineimmunesciences.com/news/news-details/2024/Alpine-Immune-Sciences-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results/defaul |
| Alpine Immune - Alpine Immune Sciences Provides Corporate Update and ... https://ir.alpineimmunesciences.com/news/news-details/2022/Alpine-Immune-Sciences-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2 |
| Alpine Immune - Alpine Immune Sciences Shares Updated Clinical Data ... https://ir.alpineimmunesciences.com/news/news-details/2024/Alpine-Immune-Sciences-Shares-Updated-Clinical-Data-from-Povetacicept-in-IgA-Nephropathy/de |
| Alpine Immune - Financials - SEC Filings https://ir.alpineimmunesciences.com/financials/sec-filings/default.aspx |
| Alpine Immune - Alpine Immune Sciences to Report Fourth Quarter and ... https://ir.alpineimmunesciences.com/news/news-details/2023/Alpine-Immune-Sciences-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results-03-15- |
ir.alpineimmunesciences.com Httpheader
| Date: Mon, 13 May 2024 12:56:32 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 8832cf1f69b62b86-LAX |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: cloudflare |
ir.alpineimmunesciences.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="6CQSdUS5BXAAKtAMtQuBNEiJbDkNn1Jw9wVUMo7CChc" name="google-site-verification"/ |
ir.alpineimmunesciences.com Html To Plain Text
Overview News Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Analyst Coverage Financials Quarterly Results SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Investor Relations Overview News Events & Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Analyst Coverage Financials Quarterly Results SEC Filings Governance Governance Documents Executive Management Board of Directors Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Corporate Overview Alpine Immune Sciences, Inc., is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. Latest News View all news Latest Presentation Latest Events View All Events Latest Quarterly Reports View All Financial Reports Contact Us Temre JohnsonInvestor Relations and Corporate Communications 000-0000-0000Send Email Visit our Twitter page Visit our LinkedIn page Quick Links SEC Filings Investor FAQs Information Request Form Pipeline & Programs Clinical Trials Management Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Alpine Immune Sciences, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Alpine Immune Sciences to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & Presentations Unsubscribe Email Alert Sign Up ConfirmationREQUEST A MEETING WITH MANAGEMENT Legal Site Map © Alpine Immune Sciences - All rights reserved Powered By Q4 Inc. 5.122.0.3 (opens in new...
ir.alpineimmunesciences.com Whois
Domain Name: ALPINEIMMUNESCIENCES.COM Registry Domain ID: 1882649139_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-18T13:32:44Z Creation Date: 2014-10-28T22:15:03Z Registry Expiry Date: 2025-10-28T22:15:03Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: MAYA.NS.CLOUDFLARE.COM Name Server: RAJEEV.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T17:23:34Z <<<